| 前收市價 | 51.10 |
| 開市 | 51.15 |
| 買盤 | 57.50 |
| 賣出價 | 61.95 |
| 拍板 | 165.00 |
| 到期日 | 2026-01-16 |
| 今日波幅 | 51.10 - 51.15 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
ZacksAbbott's (ABT) EPD Expansion Continues Despite FX Headwind
Banking on the successful execution of its Branded Generic operating model, Abbott's (ABT) EPD is well-positioned for sustained growth in many of the growing pharmaceutical markets.
ZacksThe Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine
Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine are included in this Analyst Blog.
ZacksWall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?
Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
